المؤلفون: Dhanji N; Modeling & Meta-Analysis, OPEN Health, Oxford, UK., Decimoni TC; Health Economics and Outcomes Research, Bristol Myers Squibb, São Paulo, SP, Brazil., Dyer MTD; WW Health Economics and Outcomes Research, Bristol Myers Squibb, Uxbridge, UK., May JR; WW Health Economics and Outcomes Research, Bristol Myers Squibb, Uxbridge, UK., van de Wetering G; Modeling & Meta-Analysis, OPEN Health, Rotterdam, Netherlands., Petersohn S; Modeling & Meta-Analysis, OPEN Health, Rotterdam, Netherlands., Nickel K; Modeling & Meta-Analysis, OPEN Health, Berlin, Germany., Silva A; Commercialization Intercon Medical, Medical and Regulatory Affairs, São Paulo, SP, Brazil., Muniz DQB; Hospital Sírio-Libanês, São Paulo, Brazil., Casagrande D Oliveira AP; Health Economics and Outcomes Research, Bristol Myers Squibb, São Paulo, SP, Brazil.

المصدر: Journal of medical economics [J Med Econ] 2023 Jan-Dec; Vol. 26 (1), pp. 1108-1121.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Renal Cell*/drug therapy , Carcinoma, Renal Cell*/pathology , Kidney Neoplasms*/drug therapy , Kidney Neoplasms*/pathology, Humans ; Nivolumab/therapeutic use ; Ipilimumab/therapeutic use ; Axitinib/therapeutic use ; Prognosis ; Cost-Benefit Analysis ; Brazil ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Delivery of Health Care

المؤلفون: Cordeiro MD; Divisão de Urologia, Faculdade de Medicina da Universidade de São Paulo, Instituto do Câncer de Estado de São Paulo, São Paulo, Brazil. Electronic address: mauriciocordeiro99@yahoo.com., Ilario EN; Divisão de Urologia, Faculdade de Medicina da Universidade de São Paulo, Instituto do Câncer de Estado de São Paulo, São Paulo, Brazil., Abe DK; Divisão de Urologia, Faculdade de Medicina da Universidade de São Paulo, Instituto do Câncer de Estado de São Paulo, São Paulo, Brazil., Carvalho PA; Divisão de Urologia, Faculdade de Medicina da Universidade de São Paulo, Instituto do Câncer de Estado de São Paulo, São Paulo, Brazil., Muniz DQB; Divisão de Oncologia, Instituto do Câncer de Estado de São Paulo, São Paulo, Brazil., Sarkis AS; Divisão de Urologia, Faculdade de Medicina da Universidade de São Paulo, Instituto do Câncer de Estado de São Paulo, São Paulo, Brazil., Coelho RF; Divisão de Urologia, Faculdade de Medicina da Universidade de São Paulo, Instituto do Câncer de Estado de São Paulo, São Paulo, Brazil., Guimarães RM; Divisão de Urologia, Faculdade de Medicina da Universidade de São Paulo, Instituto do Câncer de Estado de São Paulo, São Paulo, Brazil., Haddad MV; Divisão de Urologia, Faculdade de Medicina da Universidade de São Paulo, Instituto do Câncer de Estado de São Paulo, São Paulo, Brazil., Nahas WC; Divisão de Urologia, Faculdade de Medicina da Universidade de São Paulo, Instituto do Câncer de Estado de São Paulo, São Paulo, Brazil.

المصدر: Clinical genitourinary cancer [Clin Genitourin Cancer] 2022 Apr; Vol. 20 (2), pp. 102-106. Date of Electronic Publication: 2021 Nov 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Renal Cell*/pathology , Kidney Neoplasms*/pathology, Aged ; Humans ; Lymphocyte Count ; Lymphocytes/pathology ; Male ; Middle Aged ; Neutrophils/pathology ; Prognosis ; Retrospective Studies

المؤلفون: Maluf FC; Latin American Cooperative Oncology Group, Porto Alegre, Brazil; Beneficência Portuguesa de São Paulo, São Paulo, Brazil; Hospital Israelita Albert Einstein, São Paulo, Brazil. Electronic address: maluffc@uol.com.br., Schutz FA; Latin American Cooperative Oncology Group, Porto Alegre, Brazil; Beneficência Portuguesa de São Paulo, São Paulo, Brazil., Cronemberger EH; Latin American Cooperative Oncology Group, Porto Alegre, Brazil; Centro Regional Integrado de Oncologia, Fortaleza, Brazil., Luz MA; Hospital Erasto Gaertner, Curitiba, Brazil., Martins SPS; Cepho-FMABC, Santo André, Brazil., Muniz DQB; Instituto do Câncer do Estado de São Paulo (ICESP), São Paulo, Brazil., Bastos DA; Latin American Cooperative Oncology Group, Porto Alegre, Brazil; Instituto do Câncer do Estado de São Paulo (ICESP), São Paulo, Brazil., Cárcano FM; Hospital de Câncer de Barretos, Barretos, Brazil., Smaletz O; Latin American Cooperative Oncology Group, Porto Alegre, Brazil; Hospital Israelita Albert Einstein, São Paulo, Brazil., Soares A; Latin American Cooperative Oncology Group, Porto Alegre, Brazil; Hospital Israelita Albert Einstein, São Paulo, Brazil; Centro Paulista de Oncologia - Oncoclinicas, São Paulo, Brazil., Peixoto FA; Instituto COI de Educação, Pesquisa e Gestão em Saúde, Rio de Janeiro, Brazil., Gomes AJ; Liga Norte Riograndense Contra o Câncer, Natal, Brazil., Cruz FM; IBCC Oncologia - Centro Universitário São Camilo, São Paulo, Brazil., Franke FA; Oncosite - Centro de Pesquisa Clínica, Ijuí, Brazil., Herchenhorn D; Latin American Cooperative Oncology Group, Porto Alegre, Brazil; Oncologia D'OR/Instituto D'OR de Ensino e Pesquisa, Rio de Janeiro, Brazil., Dos Santos TM; Latin American Cooperative Oncology Group, Porto Alegre, Brazil., Fabricio VC; Janssen Pharmaceuticals, Argentina., Gidekel R; Janssen Pharmaceuticals, Argentina., Werutsky G; Latin American Cooperative Oncology Group, Porto Alegre, Brazil., de Jesus RG; Latin American Cooperative Oncology Group, Porto Alegre, Brazil., Souza VC; Latin American Cooperative Oncology Group, Porto Alegre, Brazil; Oncologia D'OR, Salvador, Brazil., Fay AP; Latin American Cooperative Oncology Group, Porto Alegre, Brazil; PUCRS School of Medicine, Porto Alegre, Brazil; Grupo Oncoclínicas, Porto Alegre, Brazil.

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Oct 13; Vol. 158, pp. 63-71. Date of Electronic Publication: 2021 Oct 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Nader Marta G; Instituto do Cancer do Estado de Sao Paulo, Av. Dr. Arnaldo, 251, Sao Paulo, SP, 01246-000, Brazil. guilherme.marta@usp.br., Isaacsson Velho P; Johns Hopkins Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD, USA.; Hospital Moinhos de Vento, Porto Alegre, Brazil., Bonadio RRC; Instituto do Cancer do Estado de Sao Paulo, Av. Dr. Arnaldo, 251, Sao Paulo, SP, 01246-000, Brazil., Nardo M; Instituto do Cancer do Estado de Sao Paulo, Av. Dr. Arnaldo, 251, Sao Paulo, SP, 01246-000, Brazil., Faraj SF; Instituto do Cancer do Estado de Sao Paulo, Av. Dr. Arnaldo, 251, Sao Paulo, SP, 01246-000, Brazil., de Azevedo Souza MCL; Instituto do Cancer do Estado de Sao Paulo, Av. Dr. Arnaldo, 251, Sao Paulo, SP, 01246-000, Brazil., Muniz DQB; Instituto do Cancer do Estado de Sao Paulo, Av. Dr. Arnaldo, 251, Sao Paulo, SP, 01246-000, Brazil., Bastos DA; Instituto do Cancer do Estado de Sao Paulo, Av. Dr. Arnaldo, 251, Sao Paulo, SP, 01246-000, Brazil., Dzik C; Instituto do Cancer do Estado de Sao Paulo, Av. Dr. Arnaldo, 251, Sao Paulo, SP, 01246-000, Brazil.

المصدر: Pathology oncology research : POR [Pathol Oncol Res] 2020 Oct; Vol. 26 (4), pp. 2489-2497. Date of Electronic Publication: 2020 Jun 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Media S. A Country of Publication: Switzerland NLM ID: 9706087 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2807 (Electronic) Linking ISSN: 12194956 NLM ISO Abbreviation: Pathol Oncol Res Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Biomarkers, Tumor/*blood , Carcinoma, Renal Cell/*immunology , Kidney Neoplasms/*immunology, Adolescent ; Adult ; Aged ; Aged, 80 and over ; Carcinoma, Renal Cell/drug therapy ; Child ; Female ; Humans ; Indazoles/therapeutic use ; Inflammation/blood ; Kidney Neoplasms/drug therapy ; Lymphocyte Count ; Male ; Middle Aged ; Neutrophils ; Platelet Count ; Prognosis ; Pyrimidines/therapeutic use ; Sulfonamides/therapeutic use ; Sunitinib/therapeutic use ; Young Adult

المؤلفون: Falcao CK; Department of Endocrinology and Metabolism, Hospital das Clinicas, Faculdade de Medicina da Universidade de Sao Paulo, São Paulo, Brazil., Cabral MCS; Department of Endocrinology and Metabolism, Hospital das Clinicas, Faculdade de Medicina da Universidade de Sao Paulo, São Paulo, Brazil., Mota JM; Division of Oncology, Instituto do Câncer do Estado de São Paulo, Universidade de São Paulo, São Paulo, Brazil., Arbache ST; Division of Dermatology, Hospital das Clinicas, Faculdade de Medicina da Universidade de Sao Paulo, São Paulo, Brazil., Costa-Riquetto AD; Department of Endocrinology and Metabolism, Hospital das Clinicas, Faculdade de Medicina da Universidade de Sao Paulo, São Paulo, Brazil., Muniz DQB; Division of Oncology, Instituto do Câncer do Estado de São Paulo, Universidade de São Paulo, São Paulo, Brazil., Cury-Martins J; Division of Dermatology, Hospital das Clinicas, Faculdade de Medicina da Universidade de Sao Paulo, São Paulo, Brazil., Almeida MQ; Department of Endocrinology and Metabolism, Hospital das Clinicas, Faculdade de Medicina da Universidade de Sao Paulo, São Paulo, Brazil., Kaczemorska PC; Department of Endocrinology and Metabolism, Hospital das Clinicas, Faculdade de Medicina da Universidade de Sao Paulo, São Paulo, Brazil., Nery M; Department of Endocrinology and Metabolism, Hospital das Clinicas, Faculdade de Medicina da Universidade de Sao Paulo, São Paulo, Brazil., Teles MG; Department of Endocrinology and Metabolism, Hospital das Clinicas, Faculdade de Medicina da Universidade de Sao Paulo, São Paulo, Brazil.

المصدر: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2019 Aug 01; Vol. 104 (8), pp. 3245-3248.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Immunological/*adverse effects , Carcinoma, Renal Cell/*drug therapy , Kidney Neoplasms/*drug therapy , Lipodystrophy/*chemically induced , Nivolumab/*adverse effects , Programmed Cell Death 1 Receptor/*antagonists & inhibitors, Female ; Humans ; Middle Aged

المؤلفون: Vasconcellos VF; Instituto do Cancer do Estado de São Paulo, São Paulo, Brazil., Bastos DA; Instituto do Cancer do Estado de São Paulo, São Paulo, Brazil.; Hospital Sírio-Libanês, São Paulo, Brazil., Pereira AAL; Instituto do Cancer do Estado de São Paulo, São Paulo, Brazil.; Hospital Sírio-Libanês, São Paulo, Brazil., Watarai GY; Instituto do Cancer do Estado de São Paulo, São Paulo, Brazil., Pereira BR; Instituto do Cancer do Estado de São Paulo, São Paulo, Brazil., de Godoy A; Instituto do Cancer do Estado de São Paulo, São Paulo, Brazil., Almeida-Silva J; Instituto do Cancer do Estado de São Paulo, São Paulo, Brazil., Muniz DQB; Instituto do Cancer do Estado de São Paulo, São Paulo, Brazil.; Hospital Sírio-Libanês, São Paulo, Brazil., Guglielmetti GB; Instituto do Cancer do Estado de São Paulo, São Paulo, Brazil., Nahas WC; Instituto do Cancer do Estado de São Paulo, São Paulo, Brazil., Dzik C; Instituto do Cancer do Estado de São Paulo, São Paulo, Brazil.; Hospital Sírio-Libanês, São Paulo, Brazil.

المصدر: Journal of global oncology [J Glob Oncol] 2019 Feb; Vol. 5, pp. 1-8.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101674751 Publication Model: Print Cited Medium: Internet ISSN: 2378-9506 (Electronic) Linking ISSN: 23789506 NLM ISO Abbreviation: J Glob Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Chorionic Gonadotropin/*metabolism , Neoplasms, Germ Cell and Embryonal/*drug therapy , Neoplasms, Germ Cell and Embryonal/*mortality , Testicular Neoplasms/*drug therapy , alpha-Fetoproteins/*metabolism, Adolescent ; Adult ; Brazil ; Disease-Free Survival ; Drug Therapy ; Humans ; Male ; Middle Aged ; Multivariate Analysis ; Neoplasms, Germ Cell and Embryonal/metabolism ; Prognosis ; Retrospective Studies ; Tertiary Care Centers ; Testicular Neoplasms/metabolism ; Testicular Neoplasms/mortality ; Treatment Outcome ; Young Adult

المؤلفون: Isaacsson Velho P; Pedro Isaacsson Velho, Johns Hopkins University, Baltimore, MD, and Hospital Moinhos de Vento, Porto Alegre; and Mirella Nardo, Manoel Carlos Leonardi de Azevedo Souza, Renata R.C. Colombo Bonadio, Guilherme Nader Marta, David Q.B. Muniz, Diogo Assed Bastos, and Carlos Dzik, Instituto do Cancer do Estado de Sao Paulo, São Paulo, Brazil., Nardo M; Pedro Isaacsson Velho, Johns Hopkins University, Baltimore, MD, and Hospital Moinhos de Vento, Porto Alegre; and Mirella Nardo, Manoel Carlos Leonardi de Azevedo Souza, Renata R.C. Colombo Bonadio, Guilherme Nader Marta, David Q.B. Muniz, Diogo Assed Bastos, and Carlos Dzik, Instituto do Cancer do Estado de Sao Paulo, São Paulo, Brazil., Souza MCLA; Pedro Isaacsson Velho, Johns Hopkins University, Baltimore, MD, and Hospital Moinhos de Vento, Porto Alegre; and Mirella Nardo, Manoel Carlos Leonardi de Azevedo Souza, Renata R.C. Colombo Bonadio, Guilherme Nader Marta, David Q.B. Muniz, Diogo Assed Bastos, and Carlos Dzik, Instituto do Cancer do Estado de Sao Paulo, São Paulo, Brazil., Bonadio RRCC; Pedro Isaacsson Velho, Johns Hopkins University, Baltimore, MD, and Hospital Moinhos de Vento, Porto Alegre; and Mirella Nardo, Manoel Carlos Leonardi de Azevedo Souza, Renata R.C. Colombo Bonadio, Guilherme Nader Marta, David Q.B. Muniz, Diogo Assed Bastos, and Carlos Dzik, Instituto do Cancer do Estado de Sao Paulo, São Paulo, Brazil., Marta GN; Pedro Isaacsson Velho, Johns Hopkins University, Baltimore, MD, and Hospital Moinhos de Vento, Porto Alegre; and Mirella Nardo, Manoel Carlos Leonardi de Azevedo Souza, Renata R.C. Colombo Bonadio, Guilherme Nader Marta, David Q.B. Muniz, Diogo Assed Bastos, and Carlos Dzik, Instituto do Cancer do Estado de Sao Paulo, São Paulo, Brazil., Muniz DQB; Pedro Isaacsson Velho, Johns Hopkins University, Baltimore, MD, and Hospital Moinhos de Vento, Porto Alegre; and Mirella Nardo, Manoel Carlos Leonardi de Azevedo Souza, Renata R.C. Colombo Bonadio, Guilherme Nader Marta, David Q.B. Muniz, Diogo Assed Bastos, and Carlos Dzik, Instituto do Cancer do Estado de Sao Paulo, São Paulo, Brazil., Bastos DA; Pedro Isaacsson Velho, Johns Hopkins University, Baltimore, MD, and Hospital Moinhos de Vento, Porto Alegre; and Mirella Nardo, Manoel Carlos Leonardi de Azevedo Souza, Renata R.C. Colombo Bonadio, Guilherme Nader Marta, David Q.B. Muniz, Diogo Assed Bastos, and Carlos Dzik, Instituto do Cancer do Estado de Sao Paulo, São Paulo, Brazil., Dzik C; Pedro Isaacsson Velho, Johns Hopkins University, Baltimore, MD, and Hospital Moinhos de Vento, Porto Alegre; and Mirella Nardo, Manoel Carlos Leonardi de Azevedo Souza, Renata R.C. Colombo Bonadio, Guilherme Nader Marta, David Q.B. Muniz, Diogo Assed Bastos, and Carlos Dzik, Instituto do Cancer do Estado de Sao Paulo, São Paulo, Brazil.

المصدر: Journal of global oncology [J Glob Oncol] 2018 Aug; Vol. 4, pp. 1-10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101674751 Publication Model: Print Cited Medium: Internet ISSN: 2378-9506 (Electronic) Linking ISSN: 23789506 NLM ISO Abbreviation: J Glob Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Renal Cell/*drug therapy , Kidney Neoplasms/*drug therapy , Pyrimidines/*therapeutic use , Sulfonamides/*therapeutic use , Sunitinib/*therapeutic use, Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/therapeutic use ; Brazil ; Carcinoma, Renal Cell/secondary ; Disease-Free Survival ; Female ; Humans ; Indazoles ; Kidney Neoplasms/pathology ; Male ; Middle Aged ; Protein Kinase Inhibitors/therapeutic use ; Retrospective Studies ; Treatment Outcome ; Young Adult